BIAF

bioAffinity Technologies, Inc.

BIAF, USA

bioAffinity Technologies, Inc. engages in developing non-invasive diagnostics to detect early-stage lung cancer and other diseases of the lung using flow cytometry and automated analysis in the United States. It operates through two segments: Diagnostic Research and Development; and Laboratory Services. The company offers CyPath lung which uses flow cytometry technology to detect and analyze cell populations in a person's sputum, or phlegm, to find characteristics indicative of lung cancer, including cancer and/or cancer-related cells that have shed from a lung tumor. bioAffinity Technologies, Inc. was incorporated in 2014 and is based in San Antonio, Texas.

https://www.bioaffinitytech.com

Stock Price

$0.00

0%

decrease compared to yesterday.

Dividend

Frequency:

N/A

Rate:

N/A

Next Payout:

N/A
BIAF
stock
BIAF

Cancer test lab keeps gold-standard accreditation after inspection Stock Titan

Read more →
BIAF
stock
BIAF

bioAffinity Labs Maintain CAP Accreditation, Supporting CyPath Lung TipRanks

Read more →

Showing 2 of 10

Analyst Ratings & Sentiment

(Last Updated 2025-09-30)

Rating:

HOLD

Target Price:

$6

Analyst Picks

Strong Buy

0

Buy

0

Hold

1

Sell

0

Strong Sell

0

Finn Analysis

(Last Updated 2025-09-30)

Health Score

Price to Book Ratio (P/B)

-

Very Low

0.16

Low ≤ 1

High ≥ 3

Return on Equity (ROE)

-

Very Low

-56.74 %

Low ≤ 5%

High ≥ 25%

Return on Assets (ROA)

-

Very Low

-43.75 %

Low ≤ 2%

High ≥ 10%

Free Cash Flow - Revenue % (FCF)

-

Very Low

-171.77 %

Low ≤ 5%

High ≥ 15%

Debt to Equity

-

Very High

0.30

Low ≥ 1

High ≤ 0.3

Investors

* Institutions hold a combined 2.26% of the total shares of bioAffinity Technologies, Inc.

1.

Geode Capital Management, LLC

(0.4243%)

since

2025/06/30

2.

Fidelity Extended Market Index

(0.3436%)

since

2025/07/31

3.

Vanguard Institutional Extnd Mkt Idx Tr

(0.1976%)

since

2025/07/31

4.

Hanson Mcclain Inc

(0.1817%)

since

2025/06/30

5.

Sheaff Brock Investment Advisors, LLC

(0.1817%)

since

2025/03/31

6.

Vanguard Group Inc

(0.1374%)

since

2025/06/30

7.

CapTrust Financial Advisors

(0.0943%)

since

2025/06/30

8.

IFP Advisors, LLC

(0.0845%)

since

2025/06/30

9.

Fidelity Series Total Market Index

(0.0711%)

since

2025/07/31

10.

Fidelity Nasdaq Composite Index

(0.0611%)

since

2025/07/31

11.

State Street Corp

(0.0595%)

since

2025/06/30

12.

XTX Topco Ltd

(0.0528%)

since

2025/06/30

13.

StoneX Group Inc

(0.0514%)

since

2025/06/30

14.

Fidelity Total Market Index

(0.0463%)

since

2025/07/31

15.

Northern Trust Corp

(0.0462%)

since

2025/06/30

16.

Creative Planning Inc

(0.0409%)

since

2025/06/30

17.

Spartan Total Market Index Pool G

(0.0374%)

since

2025/07/31

18.

SPROTT INC.

(0.0338%)

since

2025/06/30

19.

NT Ext Equity Mkt Idx Fd - NL

(0.0318%)

since

2025/06/30

20.

NT Ext Equity Mkt Idx Fd - DC - NL - T2

(0.0247%)

since

2025/06/30

21.

NT Ext Equity Mkt Idx Fd - L

(0.0144%)

since

2025/06/30

22.

Northern Trust Extended Eq Market Idx

(0.0144%)

since

2025/06/30

23.

Tower Research Capital LLC

(0.0106%)

since

2025/06/30

24.

Citigroup Inc

(0.005%)

since

2025/06/30

25.

NT Ext Eq Mkt Indx Fd DC Lending Tier 5

(0.0041%)

since

2025/06/30

26.

NT Ext Eq Mkt Indx Fd DC Lend T3

(0.0034%)

since

2024/12/31

27.

Spartan Extended Market Index Pool F

(0.0024%)

since

2025/07/31

28.

Bank of America Corp

(0.0007%)

since

2025/06/30

29.

Morgan Stanley - Brokerage Accounts

(0.0003%)

since

2025/06/30

30.

UBS Group AG

(0.0001%)

since

2025/06/30

31.

Warberg Asset Management LLC

(0%)

since

2025/06/30

32.

Barclays PLC

(0%)

since

2025/06/30

33.

Citadel Advisors Llc

(0%)

since

2025/03/31

* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.

Earnings History

EPS ActualEPS EstimateEPS DifferenceSurprise Percent

Upcoming Earnings Release

Date

—

EPS Estimate

—

Latest Release

Date

2025-09-30

EPS Actual

-4.74

EPS Estimate

-0.0942

EPS Difference

-4.6458

Surprise Percent

-4931.8471%

Investing Fit Scorecard

(Last Updated 2025-09-30)

Deep Value
Strong Deep Value(6.5)
Defensive
Highly Defensive(7)
Dividend
Weak Dividend Profile(1.5)
Economic Moat
Some Competitive Advantage(4.8)
GARP
Fair GARP(3.5)
Growth
Weak Growth Prospect(2)
Momentum
No Momentum(3)
Net Net
Possible Net-Net(3.5)
Quality
Low Quality Business(2.5)
Value
Fair Value(5)

Income Statement

(Last Updated 2025-09-30)

Revenue

$ 0

Cost Of Revenue

$ 0

Gross Profit

$ 0

Operating Expenses

$ 0

Operating Income

$ 0

Interest Expense

$ 0

Pretax Income

$ 0

Net Income

$ 0

Income Tax Expense

$ 0

EBITDA

$ 0

Total Other Income Expense Net

$ 0

Earnings Per Share

0

Dividends Per Share

0

Shares Outstanding

0

Operating Margin

0%

Trend

Balance Sheet

(Last Updated 2025-09-30)

Cash

$ 0

Short Term Investments

$ 0

Receivables

$ 0

Inventories

$ 0

Total Current Assets

$ 0

Property Plant Equipment

$ 0

Total Assets

$ 0

Payables

$ 0

Short Term Debt

$ 0

Long Term Debt

$ 0

Total Liabilities

$ 0

Equity

$ 0

Trend

Cash Flow

(Last Updated 2025-09-30)

Net Income

$ 0

Depreciation

$ 0

Change In Working Capital

$ 0

Cash From Operations

$ 0

Capital Expenditures

$ 0

Cash From Investing

$ 0

Cash From Financing

$ 0

Net Change In Cash

$ 0

Trend

Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.